uniQure N.V. (QURE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

PAASHEUVELWEG 25A AMSTERDAM, NETHERLANDS 1105 BP

uniQure N.V. develops gene therapy products that offer the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.

Data based on most recent fiscal year report
Market Cap2.712 Billion Shares Outstanding43.62 Million Avg Volume774.728 Thousand
1-Yr BETA vs S&P TR0.901 Current Ratio11.85 Quick Ratio11.85
View SEC Filings from QURE instead.

View recent insider trading info

Funds Holding QURE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding QURE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

31 Thousand total shares from 12 transactions

Exercise Derivative Conversion (M)

21.4 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KAPUSTA MATTHEW C CEO, CFO, MANAGING DIRECTOR

  • Officer
  • Director
318,542 2020-03-18 14

KLEMT CHRISTIAN CHIEF ACCOUNTING OFFICER

  • Officer
57,018 2020-03-04 5

SOTEROPOULOS PAULA

  • Director
4,486 2020-02-27 6

VAN DEVENTER SANDER EVP, RESEARCH & PRODUCT DEV.

  • Officer
71,458 2020-02-27 4

SCHAFFER DAVID

  • Director
46,978 2020-02-27 2

ASTLEY-SPARKE PHILIP

  • Director
8,068 2020-02-27 4

KAYE JACK

  • Director
16,191 2020-02-27 2

KUTA ALEXANDER EDWARD III EXECUTIVE VP, OPERATIONS

  • Officer
59,090 2020-02-27 9

BALACHANDRAN MADHAVAN

  • Director
8,068 2020-02-27 2

SPRINGHORN JEREMY P.

  • Director
8,068 2020-02-27 2

MEEK DAVID D.

  • Director
4,571 2020-02-27 2

GUT ROBERT CHIEF MEDICAL OFFICER

  • Officer
  • Director
45,875 2020-02-27 4

FIRUTA PAUL E EVP, CHIEF COMMERCIAL OFFICER

0 2020-01-28 0

ZELENKOFSKE STEVEN EVP, CHIEF MEDICAL OFFICER

0 2020-01-28 0

LEWIS WILLIAM CHAIRMAN AND CEO

  • Officer
  • Director
135,092 2020-01-03 0

KESON-BROOKES MAIKEN CLO & CORP. SECRETARY

  • Officer
0 2019-11-29 0

MCMILLAN SCOTT T. CHIEF OPERATING OFFICER

  • Officer
20,432 2019-01-28 0

FORUNIQURE B.V.

FORBION 1 MANAGEMENT B.V.

  • 10% Owner
4,376,883 2018-04-23 0

CANTOR MARIA E SVP, INVESTOR REL. & COMM.

  • Officer
92,439 2018-01-26 0

GAREN JONATHAN CHIEF BUSINESS OFFICER

  • Officer
93,638 2018-01-26 0

PETRY HARALD CHIEF SCIENTIFIC OFFICER

  • Officer
0 2017-06-28 0

MEYER CHRISTIAN CHIEF MEDICAL OFFICER

  • Officer
0 2017-01-27 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-03-18 S 1,438 $42.40 d 318,742 318,542.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-03-18 M 5,626 $7.53 a 324,168 318,542.00 direct

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-03-18 M 5,626 a 87,035 318,542.00 direct

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-03-18 S 2,100 $41.45 d 320,180 318,542.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-03-18 S 200 $43.70 d 318,542 318,542.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-03-18 S 1,888 $40.57 d 322,280 318,542.00 direct yes

KLEMT CHRISTIAN - Officer CHIEF ACCOUNTING OFFICER

2020-03-04 S 2,250 $54.00 d 57,018 57,018.00 direct yes

KLEMT CHRISTIAN - Officer CHIEF ACCOUNTING OFFICER

2020-03-04 S 13,500 $52.00 d 59,268 57,018.00 direct yes

KLEMT CHRISTIAN - Officer CHIEF ACCOUNTING OFFICER

2020-03-04 M 15,750 d 2,250 57,018.00 direct

KLEMT CHRISTIAN - Officer CHIEF ACCOUNTING OFFICER

2020-03-04 M 15,750 $26.41 a 72,768 57,018.00 direct

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2020-02-27 A 21,719 a 21,719 59,090.00 direct

BALACHANDRAN MADHAVAN - Director

2020-02-27 A 2,063 a 8,068 8,068.00 direct

KLEMT CHRISTIAN - Officer CHIEF ACCOUNTING OFFICER

2020-02-27 A 14,479 a 14,479 57,018.00 direct

SPRINGHORN JEREMY P. - Director

2020-02-27 A 2,063 a 8,068 8,068.00 direct

ASTLEY-SPARKE PHILIP - Director

2020-02-27 A 3,620 a 3,620 8,068.00 direct

MEEK DAVID D. - Director

2020-02-27 A 2,063 a 4,571 4,571.00 direct

SOTEROPOULOS PAULA - Director

2020-02-27 A 3,620 a 3,620 4,486.00 direct

VAN DEVENTER SANDER - Officer EVP, RESEARCH & PRODUCT DEV.

2020-02-27 A 12,380 a 61,599 71,458.00 direct

KUTA ALEXANDER EDWARD III - Officer EXECUTIVE VP, OPERATIONS

2020-02-27 A 12,380 a 59,090 59,090.00 direct

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-02-27 A 59,278 a 59,278 318,542.00 direct

KLEMT CHRISTIAN - Officer CHIEF ACCOUNTING OFFICER

2020-02-27 A 8,253 a 57,018 57,018.00 direct

GUT ROBERT - Director - Officer CHIEF MEDICAL OFFICER

2020-02-27 A 21,719 a 21,719 45,875.00 direct

ASTLEY-SPARKE PHILIP - Director

2020-02-27 A 2,063 a 8,068 8,068.00 direct

SCHAFFER DAVID - Director

2020-02-27 A 3,620 a 3,620 46,978.00 direct

SOTEROPOULOS PAULA - Director

2020-02-27 A 2,063 a 4,486 4,486.00 direct

KAYE JACK - Director

2020-02-27 A 3,620 a 3,620 16,191.00 direct

BALACHANDRAN MADHAVAN - Director

2020-02-27 A 3,620 a 3,620 8,068.00 direct

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-02-27 A 33,789 a 318,542 318,542.00 direct

SPRINGHORN JEREMY P. - Director

2020-02-27 A 3,620 a 3,620 8,068.00 direct

GUT ROBERT - Director - Officer CHIEF MEDICAL OFFICER

2020-02-27 A 12,380 a 45,875 45,875.00 direct

MEEK DAVID D. - Director

2020-02-27 A 3,620 a 3,620 4,571.00 direct

SCHAFFER DAVID - Director

2020-02-27 A 2,063 d 46,978 46,978.00 direct

VAN DEVENTER SANDER - Officer EVP, RESEARCH & PRODUCT DEV.

2020-02-27 A 21,719 a 21,719 71,458.00 direct

KAYE JACK - Director

2020-02-27 A 2,063 a 16,191 16,191.00 direct

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-02-19 S 200 $65.63 d 284,753 284,753.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-02-19 S 1,600 $63.05 d 290,654 284,753.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-02-19 S 4,801 $65.06 d 284,953 284,753.00 direct yes

KAPUSTA MATTHEW C - Director - Officer CEO, CFO, MANAGING DIRECTOR

2020-02-19 S 900 $64.33 d 289,754 284,753.00 direct yes

SOTEROPOULOS PAULA - Director

2020-02-05 S 1,300 $60.58 d 3,245 2,423.00 direct yes

SOTEROPOULOS PAULA - Director

2020-02-05 S 822 $61.53 d 2,423 2,423.00 direct yes

Elevate your investments